Pricing Log in Create free account

Scinai Immunotherapeutics Ltd. Sponsored ADR (SCNI) vs Vincerx Pharma, Inc. (VINC)

Scinai Immunotherapeutics Ltd. Sponsored ADR and Vincerx Pharma, Inc. are both Biotechnology companies. Scinai Immunotherapeutics Ltd. Sponsored ADR is the larger, with a market value of $640.0K against $250.0K — 2.6× the size. Vincerx Pharma, Inc. has negative trailing earnings, so its P/E is not meaningful; Scinai Immunotherapeutics Ltd. Sponsored ADR trades at 0.0×. Across the 10 metrics below, Vincerx Pharma, Inc. leads on 6 and Scinai Immunotherapeutics Ltd. Sponsored ADR on 4.

Valuation

Metric SCNI VINC Biotechnology median
P/E 0.01 n/m 8.50
P/S n/m n/m 9.71
P/B 0.05 0.03 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.28 0.17 0.64
EV/Sales n/m n/m 9.21
Earnings yield 11,368.55% (29,060.50%) (33.15%)
Free cash flow yield (2,331.48%) (32,262.57%) (25.50%)

Profitability

Metric SCNI VINC Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (3,136.43%) (56.36%)
Return on assets 0.00% (287.21%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric SCNI VINC Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (159.83%) 58.07% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SCNI VINC Biotechnology median
Debt to equity 0.02 0.00 0.00
Current ratio 1.56 1.79 4.72
Net debt to EBITDA 0.25 0.17 0.96

Dividend

Metric SCNI VINC Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric SCNI VINC Biotechnology median
Market cap 640.00k 250.00k 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack